TY - JOUR
T1 - Dynamic altruistic cooperation within breast tumors
AU - Masroni, Muhammad Sufyan Bin
AU - Lee, Kee Wah
AU - Lee, Victor Kwan Min
AU - Ng, Siok Bian
AU - Law, Chao Teng
AU - Poon, Kok Siong
AU - Lee, Bernett Teck Kwong
AU - Liu, Zhehao
AU - Tan, Yuen Peng
AU - Chng, Wee Ling
AU - Tucker, Steven
AU - Ngo, Lynette Su Mien
AU - Yip, George Wai Cheong
AU - Nga, Min En
AU - Hue, Susan Swee Shan
AU - Putti, Thomas Choudary
AU - Bay, Boon Huat
AU - Lin, Qingsong
AU - Zhou, Lihan
AU - Hartman, Mikael
AU - Loh, Tze Ping
AU - Lakshmanan, Manikandan
AU - Lee, Sook Yee
AU - Tergaonkar, Vinay
AU - Chua, Huiwen
AU - Lee, Adeline Voon Hui
AU - Yeo, Eric Yew Meng
AU - Li, Mo Huang
AU - Chang, Chan Fong
AU - Kee, Zizheng
AU - Tan, Karen Mei Ling
AU - Tan, Soo Yong
AU - Koay, Evelyn Siew Chuan
AU - Archetti, Marco
AU - Leong, Sai Mun
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Background: Social behaviors such as altruism, where one self-sacrifices for collective benefits, critically influence an organism’s survival and responses to the environment. Such behaviors are widely exemplified in nature but have been underexplored in cancer cells which are conventionally seen as selfish competitive players. This multidisciplinary study explores altruism and its mechanism in breast cancer cells and its contribution to chemoresistance. Methods: MicroRNA profiling was performed on circulating tumor cells collected from the blood of treated breast cancer patients. Cancer cell lines ectopically expressing candidate miRNA were used in co-culture experiments and treated with docetaxel. Ecological parameters like relative survival and relative fitness were assessed using flow cytometry. Functional studies and characterization performed in vitro and in vivo include proliferation, iTRAQ-mass spectrometry, RNA sequencing, inhibition by small molecules and antibodies, siRNA knockdown, CRISPR/dCas9 inhibition and fluorescence imaging of promoter reporter-expressing cells. Mathematical modeling based on evolutionary game theory was performed to simulate spatial organization of cancer cells. Results: Opposing cancer processes underlie altruism: an oncogenic process involving secretion of IGFBP2 and CCL28 by the altruists to induce survival benefits in neighboring cells under taxane exposure, and a self-sacrificial tumor suppressive process impeding proliferation of altruists via cell cycle arrest. Both processes are regulated concurrently in the altruists by miR-125b, via differential NF-κB signaling specifically through IKKβ. Altruistic cells persist in the tumor despite their self-sacrifice, as they can regenerate epigenetically from non-altruists via a KLF2/PCAF-mediated mechanism. The altruists maintain a sparse spatial organization by inhibiting surrounding cells from adopting the altruistic fate via a lateral inhibition mechanism involving a GAB1-PI3K-AKT-miR-125b signaling circuit. Conclusions: Our data reveal molecular mechanisms underlying manifestation, persistence and spatial spread of cancer cell altruism. A minor population behave altruistically at a cost to itself producing a collective benefit for the tumor, suggesting tumors to be dynamic social systems governed by the same rules of cooperation in social organisms. Understanding cancer cell altruism may lead to more holistic models of tumor evolution and drug response, as well as therapeutic paradigms that account for social interactions. Cancer cells constitute tractable experimental models for fields beyond oncology, like evolutionary ecology and game theory.
AB - Background: Social behaviors such as altruism, where one self-sacrifices for collective benefits, critically influence an organism’s survival and responses to the environment. Such behaviors are widely exemplified in nature but have been underexplored in cancer cells which are conventionally seen as selfish competitive players. This multidisciplinary study explores altruism and its mechanism in breast cancer cells and its contribution to chemoresistance. Methods: MicroRNA profiling was performed on circulating tumor cells collected from the blood of treated breast cancer patients. Cancer cell lines ectopically expressing candidate miRNA were used in co-culture experiments and treated with docetaxel. Ecological parameters like relative survival and relative fitness were assessed using flow cytometry. Functional studies and characterization performed in vitro and in vivo include proliferation, iTRAQ-mass spectrometry, RNA sequencing, inhibition by small molecules and antibodies, siRNA knockdown, CRISPR/dCas9 inhibition and fluorescence imaging of promoter reporter-expressing cells. Mathematical modeling based on evolutionary game theory was performed to simulate spatial organization of cancer cells. Results: Opposing cancer processes underlie altruism: an oncogenic process involving secretion of IGFBP2 and CCL28 by the altruists to induce survival benefits in neighboring cells under taxane exposure, and a self-sacrificial tumor suppressive process impeding proliferation of altruists via cell cycle arrest. Both processes are regulated concurrently in the altruists by miR-125b, via differential NF-κB signaling specifically through IKKβ. Altruistic cells persist in the tumor despite their self-sacrifice, as they can regenerate epigenetically from non-altruists via a KLF2/PCAF-mediated mechanism. The altruists maintain a sparse spatial organization by inhibiting surrounding cells from adopting the altruistic fate via a lateral inhibition mechanism involving a GAB1-PI3K-AKT-miR-125b signaling circuit. Conclusions: Our data reveal molecular mechanisms underlying manifestation, persistence and spatial spread of cancer cell altruism. A minor population behave altruistically at a cost to itself producing a collective benefit for the tumor, suggesting tumors to be dynamic social systems governed by the same rules of cooperation in social organisms. Understanding cancer cell altruism may lead to more holistic models of tumor evolution and drug response, as well as therapeutic paradigms that account for social interactions. Cancer cells constitute tractable experimental models for fields beyond oncology, like evolutionary ecology and game theory.
UR - http://www.scopus.com/inward/record.url?scp=85179662877&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85179662877&partnerID=8YFLogxK
U2 - 10.1186/s12943-023-01896-7
DO - 10.1186/s12943-023-01896-7
M3 - Article
C2 - 38093346
AN - SCOPUS:85179662877
SN - 1476-4598
VL - 22
JO - Molecular Cancer
JF - Molecular Cancer
IS - 1
M1 - 206
ER -